Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 11.5B | 12.0B | 11.2B | 10.7B |
| Cost of revenue | 6.9B | 7.2B | 6.8B | 6.5B |
| Gross profit | 4.6B | 4.7B | 4.4B | 4.2B |
| Operating expense | ||||
| Research & development | 815M | 785M | 774M | 760M |
| Selling general and admin | 1.7B | 2.3B | 1.7B | 1.8B |
| Other operating expenses | 668M | 678M | 687M | 682M |
| Operating income | 1.2B | 770M | 1.1B | 796M |
| Non operating interest income | ||||
| Income | 169M | 191M | 195M | 176M |
| Expense | 105M | 117M | 143M | 139M |
| Other income expense | 93M | 65M | 1.7B | 244M |
| Pretax income | 1.4B | 909M | 2.8B | 1.1B |
| Tax provision | -402M | -6.0B | 158M | 57M |
| Net income | 1.8B | 6.9B | 2.6B | 1.0B |
| Basic EPS | 0.9 | 3.3 | 1.2 | 0.5 |
| Diluted EPS | 0.8 | 3.2 | 1.2 | 0.5 |
| Basic average shares | 2.1B | 2.1B | 2.1B | 2.1B |
| Diluted average shares | 2.1B | 2.1B | 2.2B | 2.2B |
| EBITDA | 1.6B | 1.1B | 1.4B | 1.1B |
| Net income from continuing op. | 1.8B | 6.9B | 2.6B | 1.0B |
| Minority interests | 2M | -18M | 13M | 7M |
| Preferred stock dividends | — | — | — | — |